Podcast
0.25 CME/CE Credit
Menopausal Symptoms—Are You Providing the Best Care to Improve Function and Quality of Life? - Frankly Speaking Ep 321Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato
Most perimenopausal and menopausal individuals will experience some symptoms. Up to 80% of women report some symptoms, with vasomotor symptoms being the most commonly reported; however, other symptoms such as sleep disturbance, sexual dysfunction, and mood can be present. These symptoms can have a tremendous negative impact on quality of life and well-being, yet many women remain untreated for their symptoms even though evidence-based treatments exist. Join us to discuss effective treatments and ways you can overcome barriers to providing evidence-based menopausal therapy.
Episode Reference and Resource Links:
- DePree, Barbara MD, NCMP, MMM1; Houghton, Katherine MSc2; Shiozawa, Aki DrPH, MBA3; Esterberg, Elizabeth MS4; King, Deanna D. MS, PhD3; Kim, Janet PhD3; Mancuso, Shayna DO, FACOG3. Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records. Menopause 30(1):p 70-79, January 2023. | DOI: 10.1097/GME.0000000000002095 https://journals.lww.com/menopausejournal/Fulltext/2023/01000/Treatment_and_resource_utilization_for_menopausal.11.aspx
- The North Amrican Menopause Society. (NAMS) The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause: The Journal of the North American Menopause Society. Vol.29 (7) pp 767-794. DOI: 10.1097/GME.0000000000002028
- The North American Menopause Society (NAMS). Menopause Practice: A Clinician's Guide. 6th Edition. Pepper Pike, Ohio. September 2019.
Already listened on another platform?
CME/CE Information
0.25 AMA PRA Category 1 Credits™
Release Date: 3/27/2023
Expiration Date: 3/27/2025
Learning Objectives
- Identify the most common obstacles to providing evidence-based care to manage symptoms in menopausal women
- Provide evidence-based care to manage symptoms and improve quality of life for menopausal women
Faculty
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Susan Feeney, DNP, FNP-BC, NP-C
Assistant Professor and Coordinator of the Family Nurse Practitioner Track
UMMS GSN
Disclosures
Frank J. Domino, MD: Has disclosed no relevant financial relationships.
Susan Feeney, DNP, FNP-BC, NP-C: Has disclosed no relevant financial relationships.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Obtaining Credit
Supporters and Partners
Commercial Supporter
Commercial Supporter Here
Education Partner
Education Partner here
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.